- Page 3/3
- Next Page
WEAK BUY
BUY
They make sleep apnea machines, but now make ventilators during quarter. Last-October they just reported a super quarter that pushed the stock from $180 to $220 in days. It's pulled back to $211 because of positive vaccine news. It'll get a boost from their sleep apnea machines after Covid when people will visit their doctors again.
Healthcare
DON'T BUY
Will it return to $55 (pre-Covid)? They've issued so much new dilutive stock, so he doesn't know if they can return to $55 in a year's time, maybe more like two or more years. He himself wants to take a cruise again and is confident that the company will take safety precautions to assure customers.
0
It should capitalize on restaurant closures in the current lockdown, but this stock is wildly inconsistent. SJM holds a curious assortment of products. He thinks SJM is ready to catch up, but prefers Hormel.